Glenmark Pharma returns to profit in Q4 FY25, declares final dividend

Mumbai-headquartered Glenmark Pharmaceuticals Ltd has officially announced that it has posted a net profit of Rs 4.7 crore in Q4 FY25, after a loss of Rs 1,218 crore during the same period last year.